Franklin Sun

999 total citations
24 papers, 738 citations indexed

About

Franklin Sun is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Franklin Sun has authored 24 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Urology, 12 papers in Rheumatology and 8 papers in Epidemiology. Recurrent topics in Franklin Sun's work include Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (12 papers) and Urinary Tract Infections Management (8 papers). Franklin Sun is often cited by papers focused on Urinary Bladder and Prostate Research (14 papers), Pelvic floor disorders treatments (12 papers) and Urinary Tract Infections Management (8 papers). Franklin Sun collaborates with scholars based in United States, France and United Kingdom. Franklin Sun's co-authors include Zhonghong Guan, Jon D. Morrow, Jason Gong, Tamara Bavendam, Christopher R. Chapple, Marina Brodsky, Paul Abrams, Sender Herschorn, Jean F. Wyman and Gloria Bachmann and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Diabetes Care.

In The Last Decade

Franklin Sun

23 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Franklin Sun United States	14	570	489	250	134	97	24	738
Denis Comet France	9	192 0.3×	81 0.2×	44 0.2×	54 0.4×	88 0.9×	25	348
Diego González-Segura Alsina Spain	14	36 0.1×	42 0.1×	56 0.2×	126 0.9×	113 1.2×	42	647
Yew Yoong Ding Singapore	14	56 0.1×	75 0.2×	58 0.2×	45 0.3×	7 0.1×	29	552
Milena N. Mareva United States	8	86 0.2×	76 0.2×	135 0.5×	30 0.2×	4 0.0×	8	472
Daniel Parker United States	9	34 0.1×	16 0.0×	31 0.1×	71 0.5×	21 0.2×	18	455
K. A. Pearce United States	12	19 0.0×	55 0.1×	42 0.2×	55 0.4×	21 0.2×	20	346
Imogen Koopmans United Kingdom	4	39 0.1×	37 0.1×	50 0.2×	33 0.2×	2 0.0×	5	291
A. Ravenscroft United Kingdom	9	31 0.1×	24 0.0×	41 0.2×	209 1.6×	3 0.0×	9	370
Annamaria Veronelli Italy	11	19 0.0×	103 0.2×	49 0.2×	226 1.7×	179 1.8×	14	463
Ah-Leum Ahn South Korea	8	11 0.0×	16 0.0×	283 1.1×	337 2.5×	25 0.3×	18	542

Countries citing papers authored by Franklin Sun

Since Specialization

Citations

This map shows the geographic impact of Franklin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franklin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franklin Sun more than expected).

Fields of papers citing papers by Franklin Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franklin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franklin Sun. The network helps show where Franklin Sun may publish in the future.

Co-authorship network of co-authors of Franklin Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Franklin Sun. A scholar is included among the top collaborators of Franklin Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franklin Sun. Franklin Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pop‐Busui, Rodica, Anand Patel, Christine N. Sang, et al.. (2024). Efficacy and Safety of LX9211 for Relief of Diabetic Peripheral Neuropathic Pain (RELIEF-DPN 1): Results of a Double-Blind, Randomized, Placebo-Controlled, Proof-of-Concept Study. Diabetes Care. 47(8). 1325–1332. 3 indexed citations

Pop‐Busui, Rodica, Christine N. Sang, Craig Granowitz, et al.. (2023). 103-OR: LX9211, an Orally-Administered, Non-opioid, AAK1 Inhibitor for Painful Diabetic Peripheral Neuropathy—Results from a Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study. Diabetes. 72(Supplement_1). 3 indexed citations

Cherney, David Z.I., Deepak L. Bhatt, Michael Szarek, et al.. (2023). Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease. Diabetes Obesity and Metabolism. 25(11). 3410–3414. 4 indexed citations

Pitt, Bertram, Deepak L. Bhatt, Michael Szarek, et al.. (2022). Abstract 10209: The Effect of the Dual SGLT1 and 2 Inhibitor Sotagliflozin on Cardiovascular Mortality and Hospital Readmission Rates for Heart Failure at 30 and 90 Days Post Discharge in Patients With Type 2 Diabetes Hospitalized for Worsening Heart Failure in the SOLOIST-WHF Trial. Circulation. 146(Suppl_1). 2 indexed citations

Davies, Michael J., Franklin Sun, Phillip Banks, Deepak L. Bhatt, & Bertram Pitt. (2022). Major Adverse Cardiovascular Events Across the Sotagliflozin Clinical Development Program. American Heart Journal. 254. 243–244. 1 indexed citations

Herschorn, Sender, Steven A. Kaplan, Franklin Sun, & Fady Ntanios. (2014). Do Patient Characteristics Predict Responsiveness to Treatment of Overactive Bladder With Antimuscarinic Agents?. Urology. 83(5). 1023–1029. 16 indexed citations

Carlsson, Martin, Kelly H. Zou, Ching‐Ray Yu, Kezhen Liu, & Franklin Sun. (2014). A comparison of nonparametric and parametric methods to adjust for baseline measures. Contemporary Clinical Trials. 37(2). 225–233. 5 indexed citations

Chapple, Christopher R., Tim Schneider, François Haab, et al.. (2014). Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double‐blind, placebo‐controlled EIGHT trial. British Journal of Urology. 114(3). 418–426. 28 indexed citations

DuBeau, Catherine E., Stephen R. Kraus, Tomas L. Griebling, et al.. (2012). 1352 FESOTERODINE IS EFFECTIVE AND WELL TOLERATED IN VULNERABLE ELDERLY SUBJECTS WITH URGENCY INCONTINENCE: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY. The Journal of Urology. 187(4S). 8 indexed citations

10.

Staskin, David, Martin C. Michel, Franklin Sun, Zhonghong Guan, & Jon D. Morrow. (2012). The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms. The Journal of Urology. 187(5). 1721–1726. 5 indexed citations

11.

Kaplan, Steven A., Claus G. Roehrborn, Jason Gong, Franklin Sun, & Zhonghong Guan. (2011). Add‐on fesoterodine for residual storage symptoms suggestive of overactive bladder in men receiving α‐blocker treatment for lower urinary tract symptoms. British Journal of Urology. 109(12). 1831–1840. 48 indexed citations

12.

Staskin, David, Vik Khullar, Martin C. Michel, et al.. (2011). Effects of voluntary dose escalation in a placebo‐controlled, flexible‐dose trial of fesoterodine in subjects with overactive bladder. Neurourology and Urodynamics. 30(8). 1480–1485. 28 indexed citations

13.

Wyman, Jean F., Carl G. Klutke, Kathryn L. Burgio, et al.. (2010). Effects of combined behavioral intervention and tolterodine on patient-reported outcomes.. PubMed. 17(4). 5283–90. 9 indexed citations

14.

Rogers, Rebecca G., et al.. (2009). Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 months. International Urogynecology Journal. 20(4). 381–385. 21 indexed citations

15.

Dmochowski, Roger R., Kenneth M. Peters, Jon D. Morrow, et al.. (2009). Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder. Urology. 75(1). 62–68. 78 indexed citations

16.

Chapple, Christopher R., Sender Herschorn, Paul Abrams, et al.. (2008). Tolterodine Treatment Improves Storage Symptoms Suggestive of Overactive Bladder in Men Treated With α-Blockers. European Urology. 56(3). 534–543. 137 indexed citations

17.

Rogers, Rebecca G., Gloria Bachmann, Zhanna Jumadilova, et al.. (2008). Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active women. International Urogynecology Journal. 19(11). 1551–1557. 64 indexed citations

18.

Harvey, Peter, et al.. (2007). A Randomized, Placebo‐Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacodynamic Interaction of Coadministered Amlodipine and Atorvastatin in 1660 Patients With Concomitant Hypertension and Dyslipidemia: The Respond Trial. The Journal of Clinical Pharmacology. 47(12). 1555–1569. 45 indexed citations

19.

Blank, Roy C., James LaSalle, Russell A. Reeves, et al.. (2005). Single‐Pill Therapy in the Treatment of Concomitant Hypertension and Dyslipidemia (The Amlodipine/Atorvastatin Gemini Study). Journal of Clinical Hypertension. 7(5). 264–273. 59 indexed citations

20.

Blank, Roy C., et al.. (2004). 1008-190 Amlodipine/atorvastatin single pill dual therapy improves goal attainment in the treatment of concomitant hypertension and dyslipidemia: The Gemini study. Journal of the American College of Cardiology. 43(5). A447–A447. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact